Please login to the form below
Akili Interactive
This page shows the latest Akili Interactive news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m
Digital medicine’ company Akili Interactive raises more funds. Akili Interactive, a company pioneering prescription ‘digital medicine’ for cognitive dysfunction and brain-related conditions, has raised $13 million in new funding. ... Akili says its
Latest news
-
New alliance launches to usher digital therapeutics into the mainstream
The Digital Therapeutics Alliance’s founding members include Voluntis, Propeller Health and Akili Interactive, with the latter’s video game ADHD treatment expected to be submitted for FDA approval in 2018. ... Akili CEO Eddie Martucci said: "Digital
-
Akili to submit video game ADHD treatment for US approval in 2018
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools. ... Follows trial suggesting attention benefits of its 'digital medicine' AKL-T01. Akili Interactive plans to seek FDA approval for
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Ex Sanofi boss joins Boston start-up
Among the 12 companies in PureTech's pipeline are Akili Interactive Labs, which is a collaboration between game designers and neuroscientists to spot signs of the onset of Alzheimer's
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
- Nucleus Global announces a trio of promotions
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Pfizer introduces new logo in a ‘shift from commerce to science’
- PHE study finds people who have had COVID-19 can still transmit the virus
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- New study identifies drugs that are safe to use in COVID-19 treatment
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
